Treatment of Alzheimer's Disease and Related Conditions
申请人:Churcher Ian
公开号:US20100240647A1
公开(公告)日:2010-09-23
Compounds of formula (I) inhibit microtubule affinity regulating kinase (MARK), and hence are suitable for treating diseases associated with abnormal phosphorylation of tau.
式(I)的化合物抑制微管亲和力调节激酶(MARK),因此适用于治疗与tau异常磷酸化相关的疾病。
Sugita, Shin-Ichi; Toda, Susumu; Yoshiyasu, Takashi, Molecular Crystals and Liquid Crystals Science and Technology, Section A: Molecular Crystals and Liquid Crystals, 1994, vol. 239, p. 113 - 122